{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:22:50Z","timestamp":1794493370075,"version":"4.9.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/grf.0b013e3182510a35","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T13:17:20Z","timestamp":1334668640000},"page":"433-439","source":"Crossref","is-referenced-by-count":40,"title":["Methotrexate"],"prefix":"10.1097","volume":"55","author":[{"given":"CATHERINE S.","family":"STIKA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14656566.2.3.409","article-title":"The pharmacology of methotrexate.","volume":"2","author":"Barnhart","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"R3-10-20210126","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0015-0282(16)60549-6","article-title":"Outpatient chemotherapy of unruptured ectopic pregnancy.","volume":"51","author":"Stovall","year":"1989","journal-title":"Fertil Steril"},{"key":"R4-10-20210126","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0002-9378(98)70343-6","article-title":"Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate.","volume":"178","author":"Lipscomb","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R6-10-20210126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.fertnstert.2006.06.054","article-title":"Use of 2-dose regimen of methotrexate to treat ectopic pregnancy.","volume":"87","author":"Barnhart","year":"2007","journal-title":"Fertil Steril"},{"key":"R7-10-20210126","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0015-0282(16)55858-0","article-title":"Methotrexate treatment of ectopic pregnancy: 100 cases treated by primary transvaginal injection under sonographic control.","volume":"59","author":"Fernandez","year":"1993","journal-title":"Fertil Steril"},{"key":"R8-10-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00404-003-0567-9","article-title":"Cervical pregnancy treated with transvaginal ultrasound-guided intra-amniotic instillation of methotrexate.","volume":"271","author":"Hassiakos","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"R9-10-20210126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1469-0705.1996.07050353.x","article-title":"A potentially safer route for puncture and injection of cornual ectopic pregnancies.","volume":"7","author":"Timor-Tritsch","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R11-10-20210126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1074-3804(05)81012-6","article-title":"Systemic treatment of ectopic pregnancies with single-dose methotrexate.","volume":"1","author":"Schafer","year":"1994","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"R12-10-20210126","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1067\/mob.2002.123825","article-title":"Oral methotrexate for treatment of ectopic pregnancy.","volume":"186","author":"Lipscomb","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R13-10-20210126","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0002-9378(72)90824-1","article-title":"Secretion of methotrexate into human milk.","volume":"112","author":"Johns","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"R15-10-20210126","first-page":"645","article-title":"Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.","volume":"31","author":"Hoekstra","year":"2004","journal-title":"J Rheumatol"},{"key":"R16-10-20210126","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2008.08.023","article-title":"Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.","volume":"596","author":"Maeda","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R17-10-20210126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2133\/dmpk.19.369","article-title":"Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.","volume":"19","author":"Uwai","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"R18-10-20210126","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1158\/0008-5472.CAN-03-4062","article-title":"Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.","volume":"64","author":"Breedveld","year":"2004","journal-title":"Cancer Res"},{"key":"R19-10-20210126","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1124\/dmd.111.038794","article-title":"Impact of abcc2 multidrug resistance-associated protein (MRP) 2, abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.","volume":"39","author":"Vlaming","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R20-10-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11095-007-9407-0","article-title":"Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates.","volume":"25","author":"VanWert","year":"2008","journal-title":"Pharm Res"},{"key":"R21-10-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejps.2011.03.006","article-title":"In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate.","volume":"43","author":"Elsby","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"R23-10-20210126","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(97)11476-3","article-title":"Ectopic pregnancy.","volume":"351","author":"Pisarska","year":"1998","journal-title":"Lancet"},{"key":"R26-10-20210126","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0002-9378(97)70578-7","article-title":"Methotrexate pneumonitis after systemic treatment for ectopic pregnancy.","volume":"176","author":"Horrigan","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R28-10-20210126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00001703-199506000-00003","article-title":"Ectopic pregnancy: new advances in diagnosis and treatment.","volume":"7","author":"Buster","year":"1995","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R29-10-20210126","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.jaad.2009.09.015","article-title":"Atypical methotrexate-induced ultraviolet recall phenomenon during the treatment of ectopic pregnancy.","volume":"63","author":"Wackowski","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-201206000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:55:15Z","timestamp":1618365315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201206000-00010"}},"subtitle":["The Pharmacology Behind Medical Treatment for Ectopic Pregnancy"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e3182510a35","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}